1. Targeted therapies in bladder cancer: signaling pathways, applications, and challenges
   Mei Peng et al, 2023, MedComm CrossRef
2. Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells
   Tokio Terado et al, 2022, International Journal of Oncology CrossRef
3. Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration
   Yuying Zhang et al, 2022, BMC Cancer CrossRef
4. Cryptotanshinone From Salvia miltiorrhiza Inhibits the Growth of Tumors and Enhances the Efficacy of Chemotherapy in a Gastric Cancer Mouse Model
   Wenkai Wu et al, 2022, Natural Product Communications CrossRef
5. Cryptotanshinone Inhibits Bladder Cancer Cell Malignant Progression in a Lipopolysaccharide-Induced Inflammatory Microenvironment through NLRP3 Inhibition
   Chenye Tang et al, 2024, Mediators of Inflammation CrossRef
6. Prospective pharmacological potential of cryptotanshinone in cancer therapy
   Ashif Ahamed et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef
7. Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
   Julieta Afonso et al, 2023, Cancers CrossRef